Bio Connections 2024 - Australia | Informa Connect | 28 July 2024 | Crown Promenade Melbourne, Power Street Reserve, 8 Whiteman St, Southbank VIC 3006, Australia

This event is an annual event for the biotech industry which provides a unique platform for networking, discussion and thought leadership. The conference focuses on translating medical research into commercialisation, drug discovery and development, early phase clinical trials and expediting Australia’s great science into commercialisation.

Each year it gathers a diverse mix of senior decision-makers in the industry from pharma industry leaders to investors, biotechs(both local and international companies), researchers, CROs, phase 1 units, universities, government, and regulators.

To stay informed of speaker announcements, early bird discounts and the official agenda release register your interest below.

2024 SPEAKERS

Dr Nina Webster
CEO & MD, Dimerix Limited

The Hon Gabrielle Upton FAICD
former NSW Government Minister, Board Member, The Florey Institute of Neuroscience

Dr Steven Gourlay
CEO and Managing Director, Actinogen

James Graham
CEO, Recce Pharmaceuticals

A/Prof Tina Soulis
Founder & Director, Alithia Life Sciences

Associate Professor Tam C. Nguyen
Deputy Director Research, St Vincent’s Hospital Melbourne, IC, H3Healthcare

Saurabh Jain
CEO, TrialKey

Dr Felicia Pradera
Head – Health Security Systems Australia, DMTC Limited

Nick Rich
Regional Director Business Development, Novotech

Dr Anand Gautam
Founder, G2OME Consulting

Dr Ingmar Wahlqvist
Senior Investment Manager, Brandon Capital

Sarah Meibusch
Partner, OneVentures

David Hoey
CEO, Vaxxas

Dr Craig Rayner
Director, Moderna's Regional Research Centre for Respiratory Medicines and Tropical Diseases

Dr Amanda Buttery
Director, Integrated Evidence, Medical Affairs, Moderna

Emerald Scofield
Associate, Main Sequence Ventures

Dr Kathy Nielsen
CEO, BioCurate

Dr Rita Choueiri
Partner, R&D Tax and Government Incentives National Director, Life Sciences, RSM Australia

Professor Evelin Tiralongo
Director Clinical Trial Unit, Griffith University

Dr Megan Baldwin
Founder and Chief Innovation Officer, Opthea

Ben Constable
Managing Director Australia, Lumira Ventures

A/Professor Ben Tran
Medical Oncologist, Peter MacCallum Cancer Centre

Andrew Stewart
CEO, Endpoints Capital

Damon Rasheed
CTO & Executive Director, TrialKey

Dr Craig Rogers
Director – SABRE Alliance, Defence Science & Technology Group, Department of Defence

Dr Amanda Caples
Victoria’s Lead Scientist

Dr Daniel Getts
CEO & Co-Founder, Myeloid Therapeutics

The Hon Jaala Pulford
Chair, MTPConnect, Victorian Minister for Medical Research and Innovation (2020-2022)

Samantha Cobb
CEO, Currus Biologics

Dr Rebecca McQualter
Chief Operating Officer/Acting CEO, Chimeric Therapeutics Ltd

John Kurek
Investment Director, Uniseed

Dr Andrew Brockway
CEO, Doherty Clinical Trials

Professor Sharon Goldfeld AM
Director, The Centre for Community Child Health, Royal Children’s Hospital, Theme Director, Population Health, Co-Group Leader Policy and Equity, Murdoch Children's Research Institute

Stephen Thompson
CEO, Viral Vector Manufacturing Facility

Harpreet Johal-Meredith
Director of Business Development, Resolian Bioanalytics

Rima Darwiche
CEO, Central Pharmacy Logistics

2024 Sponsors

GOLD SPONSOR:
• Trialkey

BREAKFAST BRIEFING SPONSORS:
• Novotech
• Resolian

SUPPORTING SPONSOR:
• RSM

LANYARD SPONSOR:
• FPA Patent Attorneys